Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
POLICY PAPERS
April 08, 2024
The global locus of undervaccination is increasingly shifting from the poorest countries in the world—which are eligible for support from Gavi, the Vaccine Alliance—to middle-income countries (MICs) that do not qualify for traditional Gavi support. Given these growing challenges, Gavi must rethink i...
POLICY PAPERS
January 30, 2024
For nearly 25 years, Gavi has delivered impact and value for money and remained one of the most successful global health initiatives. Gavi’s success has been driven by its use of three primary levers: (1) accelerating new vaccine introductions, (2) increasing equitable immunization coverage, and (3)...
POLICY PAPERS
December 14, 2023
The prevailing fiscal outlook alongside broader shifts in the health landscape have important implications for countries’ eligibility for support from Gavi, the Vaccine Alliance. Current projections are similar to pre-COVID estimates, but the cohort of transitioning countries face more challenging ...
POLICY PAPERS
October 02, 2023
Development economics is turning a full circle with a difference. This paper addresses the circling back to the policies in vogue during the 1980s and earlier, including industrial policies, coupled with protectionism; accounts for the regression to earlier certitudes after an extended spell of glob...
BRIEFS
June 08, 2023
To meet many of today’s most pressing challenges, we need to find new solutions. But the fastest, cheapest, and most effective way to encourage high-impact innovation isn’t always obvious. Governments, philanthropists, and the private sector typically invest in research and development (R&D) by bett...
POLICY PAPERS
May 11, 2023
The COVID pandemic has had differential effects by gender, with women experiencing higher job and income loss, increased rates of domestic violence, and mounting care burdens. We examine the extent to which MDB COVID response projects incorporated gender elements and highlight the gaps in those effo...
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...
POLICY PAPERS
October 04, 2022
In this paper, we report the results of a horizon-scanning exercise to source opportunities for global health R&D investment—that is, high-value potential biomedical innovations which are currently underfunded but which could be transformative for health, quality of life, and health security in LMIC...
POLICY PAPERS
September 20, 2022
While all corners of the world have been touched by COVID-19, countries’ experiences with the virus have certainly not been universal. Staggering divergences in outcomes between countries—in terms of lives lost, economic carnage, secondary health losses, learning loss, and social trust and cohesion,...
POLICY PAPERS
June 06, 2022
Before the pandemic, the achievement of the SDGs by 2030 was doubtful in part because of the slow pace in generating additional revenues from domestic sources. As the financing needs have increased after the pandemic, the achievement of these goals will be delayed beyond 2030, unless additional fina...